ticlopidine has been researched along with Paraneoplastic Syndromes in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Triller, R | 1 |
| Renard, T | 1 |
| de Lacharrière, O | 1 |
| Léonard, F | 1 |
| Caulet, T | 1 |
| Kalis, B | 1 |
1 other study available for ticlopidine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
[Darier's erythema annulare centrifugum and primary Vaquez polycythemia].
Topics: Aged; Erythema; Follow-Up Studies; Humans; Male; Paraneoplastic Syndromes; Phosphorus Radioisotopes; | 1984 |